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Background: No studies on continuous renal replacement therapy (CRRT) have analyzed nutritional status in
children. The objective of this study was to assess the association between mortality and nutritional status of
children receiving CRRT.
Methods: Prospective observational study to analyze the nutritional status of children receiving CRRT and its
association with mortality. The variables recorded were age, weight, sex, diagnosis, albumin, creatinine, urea, uric
acid, severity of illness scores, CRRT-related complications, duration of admission to the pediatric intensive care unit,
and mortality.
Results: The sample comprised 174 critically ill children on CRRT. The median weight of the patients was 10 kg,
35% were under percentile (P) 3, and 56% had a weight/P50 ratio of less than 0.85. Only two patients were above
P95. The mean age for patients under P3 was significantly lower than that of the other patients (p = 0.03). The
incidence of weight under P3 was greater in younger children (p = 0.007) and in cardiac patients and in those who
had previous chronic renal insufficiency (p = 0.047). The mortality analysis did not include patients with pre-existing
renal disease. Mortality was 38.9%. Mortality for patients with weight < P3 was greater than that of children with
weight > P3 (51% vs 33%; p = 0.037). In the univariate and multivariate logistic regression analyses, the only factor
associated with mortality was protein-energy wasting (malnutrition) (OR, 2.11; 95% CI, 1.067-4.173; p = 0.032).
Conclusions: The frequency of protein-energy wasting in children who require CRRT is high, and the frequency of
obesity is low. Protein-energy wasting is more frequent in children with previous end-stage renal disease and heart
disease. Underweight children present a higher mortality rate than patients with normal body weight.Background
Many critically ill children present some degree of mal-
nutrition, better known as protein-energy wasting, which
impairs their response to disease and increases their sus-
ceptibility to infection and multi-organ failure, thus lead-
ing to a substantial rise in morbidity and mortality [1,2].
Protein-energy wasting can be acute as a result of the ill-
ness causing admission to the intensive care unit and
chronic due to an underlying disease.
Children with acute kidney injury (AKI), especially those
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reproduction in any medium, provided the orhave specific nutritional needs and often receive an exces-
sive supply of carbohydrate and insufficient protein [3].
Studies in adults with chronic renal insufficiency reported
an association between nutritional status and mortality,
and some have shown that patients with a higher body
mass index (BMI) may have better survival [4].
Several authors have assessed the impact of protein-
energy wasting on long-term outcomes in children with
end-stage renal disease (ESRD) receiving dialysis. Lower
height and growth rate implies an increased mortality
risk [5]. High and low BMI and low serum albumin are
also associated with higher mortality [6].
Few authors have evaluated the nutritional status of
patients with AKI and its association with clinical
course. In a recent study of adults receiving CRRT, 4%Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Baseline characteristics of the cohort
Median (P50) IQR (P25-75)
Age (months) 18.5 4.0-81.8
Weight (kg) 10.0 5.0-21.3
PRISM score 13.0 10.0-20.0
PRISM (mortality percentage) 21.7 7.1-52.8
PIM score –2.2 –3.2 to 0.8
PIM (mortality percentage) 3.1 0.3-17.2
PELOD score 20.0 11.0-22.0
PELOD (mortality percentage) 18.5% 1.4-26.1
Number of organ failures 3.0 2.0-3.0
Lactate (mmol/L) 1.9 1.1-3.4
Initial albumin (g/dL) 3.0 2.4-3.4
Initial creatinine (mg/dL) 1.0 0.6-1.9
Initial urea (mg/dL) 63.0 44.5-106.5
PRISM, Pediatric Risk of Mortality (PRISM II); PIM, Pediatric Index of Mortality;
PELOD, Pediatric Logistic Organ Dysfunction.
Table 2 Characteristics of CRRT
Median (P50) IQR (P25-75)
Blood flow (ml/minute) 50.0 30.0-85.0
Ultrafiltrate (ml/kg/hour) 6.4 3.3-11.1
Reposition (ml/hour) 200.0 100.0-400.0
Dialysis (ml/hour) 450 250-600
Number of filters 3.0 1.0-6.0
Total duration of CRRT (hours) 92.5 39.8-248.5
CRRT: continuous renal replacement therapy.
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[7]. The incidence of AKI increased in obese patients
compared with normal-weight patients and those who
were malnourished. Nevertheless, the obese patients
receiving CRRT had a greater probability of survival
than the malnourished or morbidly obese ones [7].
We performed the first study to assess the association
between mortality and the nutritional status of children
receiving CRRT.
Methods
We analyzed nutritional status using a prospective ob-
servational registry including all critically ill children re-
ceiving CRRT who were admitted to the pediatric
intensive care unit (PICU) between 1st January 1996 and
1st June 2009 [8]. The Gregorio Marañón University
Hospital Review Board approved the study, and, at ad-
mission, parents gave their written informed consent for
the children to participate in the study.
Most patients were weighed at admission. The scale
used depended on the patient’s age. In the remaining
patients, the parents were asked about the most recent
weight and, if no recent weight was available, they were
weighed in the PICU. The variables recorded prospect-
ively at baseline were age, weight, sex, diagnosis, albumin,
creatinine, urea, and uric acid. In addition, we recorded
three severity of illness scores, namely, the Pediatric Risk
of Mortality (PRISM II) score [9], the Pediatric Index of
Mortality (PIM II) score [10], and the Pediatric Logistic
Organ Dysfunction (PELOD) score [11], as well as mortal-
ity and CRRT-related complications (complications of
catheterization [catheter-associated or other], hemorrhage,
hypotension on connection to the filter, and electrolyte
disturbances).
Weight percentiles and the real weight/P50 ratio were
calculated according to local references [12,13]. Weight
under percentile 3 (<P3) was considered protein-energy
wasting or malnutrition. We also studied the real
weight/P50 ratio using Waterlow’s modified criterion for
acute protein-energy wasting, in which a ratio less than
0.85 was considered abnormal [14].
The statistical analysis was performed using SPSS ver-
sion 16.0 (SPSS Inc., Chicago, Illinois, USA). The chi-
squared test, Fisher exact test, and Mann–Whitney test
were used to compare the qualitative and quantitative
variables. Significance was taken as a p value less than
0.05. Univariate and multivariate logistic regression ana-
lyses were performed to analyze the influence of each
factor on mortality. Variables with p < 0.1 were included
in the multivariate analysis.
Results
The study sample comprised 174 patients who had
undergone CRRT. Of these, 97 patients (55.7%) hadcongenital heart disease and 81/97 (83.5%) had under-
gone heart procedures (14 heart recipients). Baseline
characteristics of the patients and CCRT are shown in
Tables 1 and 2. Mean age was 52.3 (SD 63.8) months; 76
(43.7%) were under one year old and 105 were male
(60.3%). Mean weight was 17.7 kg (median 10 kg; IQR,
5-21.3) and 22% weighed less than 5 kg. Sixty-one
patients (35%) were under P3 and 97 (56%) had a real
weight/P50 ratio of less than 0.85.
No differences in the frequency of protein-energy
wasting were detected between sexes (weight < P3: male
36.2%, female 33.3% [p = 0.747]; real weight/P50 ratio
<0.85: male 61%, female 47.8% [p = 0.118]).
The average age of the patients weighing under P3 was
34 (SD 56.5) months, significantly lower than the other
children (62 [SD 65.7]) months (p = 0.03). The mean age
of patients with a real weight/percentile 50 ratio <0.85
was 49.4 (SD 62.6) months. These patients were younger
than those with a real weight/P50 ratio greater than
0.85; however, the differences did not reach statistical
significance (p = 0.757).
When patients were classified into 4 age sub-groups,
the incidence of weight under P3 was greater in the
younger groups. A significant difference between those
Table 3 Frequency of protein-energy wasting according to age group
Age <12 months 1-5 years 5-10 years >10 years p value
Weight < P3 35 (46.1%) 16 (39%) 4 (14.8%) 6 (20%) 0.007
Ratio* <0.85 43 (56.6%) 26 (63.4%) 13 (48.1%) 15 (50%) 0.566
* Real weight/P50 ratio.
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(p = 0.007) (Table 3). However, these differences were
not seen on testing the real weight/P50 ratio.
In terms of diagnosis, the frequency of weight under < P3
was significantly greater in patients with heart disease and
in those who had already had previous chronic renal disease
(p = 0.047). Although the incidence of protein-energy wast-
ing was also greater in these groups when the analysis was
performed using the real weight/P50 ratio, this difference
did not reach statistical significance (p = 0.092) (Table 4).
No significant differences were observed in the PIM,
PRISM, or PELOD scores between patients weighing
over or under P3 and those with a real weight/P50 ratio
over or under 0.85 (Table 5).
The incidence of hypoalbuminemia (defined as ≤2.5 g/dl)
at the beginning of CRRT was 28%, with no significant dif-
ferences between underweight patients and the remaining
patients. After hemofiltration, the incidence of hypoalbumi-
nemia diminished by 7%.
No differences were detected in the frequency of com-
plications of CRRT associated with nutrition status. The
most frequent complications were hemorrhage and
hypotension at the beginning of the procedure
(hemorrhage weight < P3 was 13.1%, weight > P3 was 9%
[p = 0.440]; hypotension weight < P3 was 37.7%, weight >
P3 was 27% [p = 0.169]).
No differences were found in the creatinine, urea, and
uric acid values before CRRT in relation to the weight per-
centile or to the real weight/P50 ratio (data not shown);
however, when we removed patients with pre-existing
renal disease, we found differences in the remaining
patients. Initial and 24-hour creatinine and urea were
lower in patients with weight < P3 (p < 0.02).Table 4 Frequency of protein-energy wasting in relation
to diagnosis
Diagnosis Weight < P3 Ratio* <0.85
Heart disease 39 (40.2%) 57 (58.8%)
Sepsis 8 (23.5%) 17 (50%)
ESRD 10 (59.9%) 14 (82.4%)





4 (15.3%) 9 (34.6%)
p value 0.047 0.092
* Real weight/P50 ratio.
ESRD, end-stage renal disease.The median duration of treatment was 78 hours (IQR,
40-186) in the < P3 weight group compared with
94.5 hours (IQR, 36-273) in the > P3 group (p = 0.309).
Global mortality was 35.6% (62 patients). The causes of
death are detailed in Table 6. The mortality analysis did
not include patients with pre-existing renal disease. Mor-
tality in the remaining patients was 38.9%. Mortality in
AKI patients with weight < P3 was greater than that of the
children with weight > P3 (51% versus 33%; p = 0.037).
No statistical differences in mortality were detected
between patients with a real weight/P50 ratio <0.85 (42.2%)
and those with a ratio >0.85 (35.1%) (p = 0.414).
In the univariate and multivariate logistic regression
analyses, the only factor that was associated with mor-
tality was protein-energy wasting (OR, 2.11; 95% CI,
1.067-4.173; p = 0.032).
In the multivariate logistic regression analysis, heart
disease was not a confounding factor.
Overall, 23% of patients were over P50 and only 2
patients were over P95; therefore, it was not possible to
study the association between obesity and mortality.
Mortality in children with hypoalbuminemia <2.5 g/dl
at the beginning of CRRT was higher (46.7%) than the that
of the other patients (33.8%), although the difference was
not statistically significant (p = 0.215). The difference was
significant in the patients who presented hypoalbumine-
mia at the end of treatment (83.3%) (p = 0.018).
Discussion
Our study is the first to analyze nutritional status in critic-
ally ill children receiving CRRT. In adults with acute renal
failure receiving CRRT, the percentage of malnutrition is










Weight < P3 20.6 6.5 17.9
Weight > P3 19.9 12.9 24.1
p value 0.601 0.139 0.190
Ratio* <0.85 20.6 9.6 23.6
Ratio* >0.85 19.7 12.2 20.3
p value 0.724 0.877 0.929
PRISM, Pediatric Risk of Mortality (PRISM II); PIM, Pediatric Index of Mortality;
PELOD, Pediatric Logistic Organ Dysfunction.
* Real weight/P50.
Table 6 Cause of death
Cause Frequency Percentage
Multi-organ failure 34 54.8
Cardiac shock 16 25.8
Brain death 6 9.7
Withdrawal of care 3 4.8
Respiratory insufficiency 2 3.2
Tumor recurrence 1 1.6
Total 62 100
Castillo et al. BMC Nephrology 2012, 13:125 Page 4 of 6
http://www.biomedcentral.com/1471-2369/13/125obesity is high. Nevertheless, the incidence of obesity in
children with AKI in our study was very low, whereas the
percentage of malnutrition was high (35%); the highest in-
cidence of weight under P3 was observed among the
youngest children. Children with previous chronic renal
insufficiency and heart disease had the highest incidence
of malnutrition. The prevalence of protein-energy wasting
among children with chronic renal insufficiency rose from
53% to 64% depending on the definition considered [14].
Twenty-five percent of children with congenital heart
disease are < P3 [15]. However, among hospitalized chil-
dren with congenital heart disease, acute and chronic
protein-energy wasting occurred in 33% and 64% of the
patients [16].
Furthermore, cardiac surgery predisposes to the devel-
opment of AKI secondary to low cardiac output,
hemolysis after surgery, and infectious complications.
Therefore, according to our study, children with heart
disease present a higher incidence of malnutrition than
other patients.
We found no association between mortality risk scores
at the beginning of CRRT and nutritional status. We cal-
culated three of the most widely used prognostic scores in
critically ill children, which provide data for a number of
clinical and analytical parameters. No differences in acute
abnormalities of these parameters were observed between
normal-weight and underweight children. However, nutri-
tional status could affect subsequent clinical course, and
these scores do not take into account nutritional factors.
In adults with AKI receiving CRRT, mortality rates fol-
low a U-shaped pattern in which undernourished patients
and morbidly obese patients are at the highest risk [7].
The anthropometric indicators with the greatest value for
predicting mortality in these patients are forearm circum-
ference, tricipital fold, and percentage of body fat [17,18].
In pediatric patients undergoing CRRT, the principal
prognostic factors are hemodynamic abnormalities, dis-
ease severity, multi-organ failure, and previous positive
balance at the beginning of the procedure [8,9,19].
In our study, mortality was greater in children whose
weight was < P3 (42.6%) than children with a normal body
weight (31.8%). Although considerable, the difference did
not reach statistical significance. It was not possible toanalyze the association between mortality and obesity,
owing to the low number of children with obesity.
As for complications, obese adults required a longer
duration of mechanical ventilation and a greater total
number of days of hospitalization [7]. We found that
children with malnutrition presented neither a greater
incidence of complications nor longer duration of treat-
ment than patients with normal body weight.
Several parameters have been recommended for moni-
toring the nutritional status of children with chronic
renal insufficiency, such as serum albumin, height,
weight, mid-arm circumference, skin fold thickness, and
head circumference [20]. Some of these parameters
(eg, height and head circumference) are useful in the
case of prolonged malnutrition, although their usefulness
is minimal in the critically ill child. Furthermore, the
folds and circumferences of the arm are not useful in
the evaluation of nutritional status in the critically ill
child, because they could be altered by hydration status
[21]. Therefore, nutritional status in critically ill children
is evaluated mainly using anthropometric measures
(weight) and biochemical analysis [21], although weight
is also altered by hydration status.
We found that children with hypoalbuminemia pre-
sented higher mortality, although the difference was not
statistically significant. Hypoalbuminemia has been asso-
ciated with increased mortality in critically ill children
[22]. Wong et al. found that children with ESRD and
serum albumin <3.5 g/dl exhibited a 90% greater risk of
death than patients with serum albumin >3.5 [6]. Never-
theless, albumin is not a good parameter for assessing
malnutrition in critical patients because of its long half-
life. Hypoalbuminemia in patients with renal failure is
caused by a combination of reduced synthesis and
increased degradation of albumin [23]. Moreover, serum
albumin is affected not only by nutritional status, but
also by fluid status, inflammation, and liver abnormal-
ities [24,25]. Serum albumin has been shown to be a
poor marker of nutritional status in severely malnour-
ished children receiving hemodialysis [26,27].
Creatinine production depends on muscle mass and is
age- and sex-related. We found that the creatinine and
urea values were lower in underweight patients both
before starting CRRT and during the first 24 hours.
Our study presents several limitations. The most im-
portant limitation is that body weight is not an ideal
method for measuring the nutritional status of critically
ill patients. Body weight is not available for all patients,
can be affected by hydration status, cannot discriminate
between acute and chronic malnutrition, and does not
enable us to evaluate the evolution of nutritional status.
Nevertheless, despite these limitations, body weight is
the most widely used parameter for determining initial
nutritional status in critically ill patients [1,14,28].
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not recorded in all patients. Other parameters such as
prealbumin and transferrin or retinol-binding protein
may prove more useful than albumin when evaluating
protein nutritional status in the critically ill patient
[21,29,30]. On the other hand, a high percentage of
patients in our study underwent cardiac surgery; there-
fore, our results may not be representative of all critic-
ally ill children who require CRRT.
Although a high percentage of children receiving
CRRT tolerate enteral nutrition [31], many receive insuf-
ficient calories and protein [3]. We did not analyze the
effect of nutrition during admission to the PICU.
Conclusions
Critically ill children who need CRRT present a high in-
cidence of malnutrition, which is greater than that of
adults. In contrast, the incidence of obesity is very low.
Protein-energy wasting is more frequent in the youngest
children, in patients with chronic renal insufficiency, and
in patients with heart disease. Mortality is higher in mal-
nourished children requiring CRRT than in those with
normal body weight, although the difference is not sta-
tistically significant. Studies analyzing the effect of nutri-
tion on the nutritional status and outcome of CRRT
patients are necessary.
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